Cleveland Clinic’s Rheumatic Lung Disease Program is currently engaged in three major multicenter trials whose common aim is to improve outcomes for patients with rheumatic disease and pulmonary hypertension or interstitial lung disease.
The SENSCIS® study, co-led by Cleveland Clinic’s Kristin Highland, MD, explores the use of nintedanib in patients with scleroderma-associated interstitial lung disease.
A man presents with myalgias, skin thickening in his arms, legs and abdomen and stiffness in his joints. The Director of the Scleroderma Program develops the differential.
Laparoscopic RYGB may become the preferred approach to decrease acid and bile reflux and preserve esophageal function in scleroderma patients.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
To clarify conflicting reports on the incidence of breast cancer in SSc, a research team studies the development of breast cancer in SSc patients and compares them with a nonscleroderma cohort of breast cancer patients.
Skin thickening figures prominently in almost all cases of systemic sclerosis. Effective treatments are scarce, but not for lack of investigations of new options. Here’s a rundown of the most promising.
Here’s stark visual evidence of why skin thickness may be the most debilitating aspect of a condition whose name comes from the Greek for “hard skin.”
Decisions about complex rheumatic conditions often must be based on expert opinions alone if RCTs aren’t available, especially when pulmonary disease is involved. Here’s how a combined rheumatology-pulmonary clinic can help.
Uncovering the nature, extent and significance of systemic vascular involvement in pulmonary arterial hypertension (PAH) may unlock a correlation to disease severity or response to therapy, leading to future treatment options
Modern treatments have transformed scleroderma from a fatal condition to a chronic illness. However, many challenges remain to find better ways to manage this debilitating disease and its many complications.